Emerging roles of endothelial cells and smooth muscle cells in transplant vascular disease

Ventura, 1995, Cardiac allograft vasculopathy: Current concepts, Am Heart J, 129, 791, 10.1016/0002-8703(95)90331-3

Dong, 1996, The pathogenesis of cardiac allograft vasculopathy, Curr Opin Cardiol, 11, 183, 10.1097/00001573-199603000-00012

Andersen, 1995, Relative importance of ischemic injury and immunological injury on the development of transplant arteriosclerosis in rabbit aortic allografts, Transplantation, 60, 631, 10.1097/00007890-199510150-00002

Young-Ramsaran, 1993, Ultrastructural evidence of cell-mediated endothelial cell injury in cardiac transplant-related accelerated arteriosclerosis, Ultrastruct Pathol, 17, 125, 10.3109/01913129309084033

Hansson, 1997, Cell-mediated immunity in atherosclerosis, Curr Opi Lipidol, 8, 301, 10.1097/00041433-199710000-00009

Lin, 1994, Comparable proximal and distal severity of intimal thickening and size of epicardial coronary arteries in transplant arteriopathy of human, J Heart Lung Transplant, 13, 824

McManus, 1994, Lipid overload and proteoglycan expression in chronic rejection of the human transplanted heart, Clin Transplant, 8, 336

Lin, 1996, Prominence of apolipoproteins B, (a), and E in the intimae of coronary arteries in transplanted human hearts: Geographic relationship to vessel wall proteoglycans, J Heart Lung Transplant, 15, 1223

McManus, 1995, Prominence of coronary arterial wall lipids in human heart allografts. Implications for pathogenesis of allograft arteriopathy, Am J Pathol, 147, 293

McDonald, 1998, The role of lipids in transplant vascular disease, Lab Invest, 78, 1187

Lin, 1996, Biglycan, decorin, and versican protein expression patterns in coronary arteriopathy of human cardiac allograft: Distinctness as compared to native atherosclerosis, J Heart Lung Transplant, 15, 1233

Rose, 1997, Role of endothelial cells in allograft rejection, Vasc Med, 2, 105, 10.1177/1358863X9700200206

Fuggle, 1998, Cell adhesion molecules in clinical renal transplantation, Transplantation, 65, 763, 10.1097/00007890-199803270-00001

Hinek, 1996, Adhesion molecules and cell surface receptors in the heart transplant-associated arteriosclerosis, Folia Histochem Cytobiol, 34, 3

Libby, 1992, Do vascular wall cytokines promote atherogenesis?, Hosp Pract, 27, 51, 10.1080/21548331.1992.11705508

Mantovani, 1997, Cytokine activation of endothelial cells: New molecules for an old paradigm, Thromb Haemost, 78, 406, 10.1055/s-0038-1657561

Cines, 1998, Endothelial cells in physiology and in the pathophysiology of vascular disorders, Blood, 91, 3527

McGill, 1998, Endothelial cells: Role in infection and inflammation, World J Surg, 22, 171, 10.1007/s002689900366

Russell, 1994, Coronary atherosclerosis in transplanted mouse hearts. III. Effects of recipient treatment with a monoclonal antibody to interferon-gamma, Transplantation, 57, 1367, 10.1097/00007890-199405150-00014

Russell, 1995, Coronary atherosclerosis in transplanted mouse hearts. IV Effects of treatment with monoclonal antibodies to intercellular adhesion molecule-1 and leukocyte function-associated antigen-1, Transplantation, 60, 724, 10.1097/00007890-199510150-00019

Akyurek, 1995, Expression of CD11b and ICAM-1 in an in vivo model of transplant arteriosclerosis, Transpl Immunol, 3, 107, 10.1016/0966-3274(95)80037-9

Labarrere, 1997, Endothelial activation and development of coronary artery disease in transplanted human hearts, JAMA, 278, 1169, 10.1001/jama.1997.03550140061041

Tedgui, 1994, Cytokines, immuno-inflammatory response and atherosclerosis, Eur Cytokine Netw, 5, 263

Suzuki, 1997, Inhibition of accelerated coronary atherosclerosis with short-term blockade of intercellular adhesion molecule-1 and lymphocyte function-associated antigen-1 in a heterotopic murine model of heart transplantation, J Heart Lung Transplant, 16, 1141

Molossi, 1995, Blockade of very late antigen-4 integrin binding to fibronectin with connecting segment-1 peptide reduces accelerated coronary arteriopathy in rabbit cardiac allografts, J Clin Invest, 95, 2601, 10.1172/JCI117962

Korom, 1998, Transplantation, 65, 854, 10.1097/00007890-199803270-00014

Nagano, 1998, Coronary arteriosclerosis after T-cell-mediated injury in transplanted mouse hearts Role of interferon-gamma, Am J Pathol, 152, 1187

Raisanen-Sokolowski, 1998, Reduced transplant arteriosclerosis in murine cardiac allografts placed in interferon-gamma knockout recipients, Am J Pathol, 152, 359

Clausell, 1994, In vivo blockade of tumor necrosis factor-alpha in cholesterol-fed rabbits after cardiac transplant inhibits acute coronary artery neointimal formation, Circulation, 89, 2768, 10.1161/01.CIR.89.6.2768

Molossi, 1993, Coronary artery endothelial interleukin-1 beta mediates enhanced fibronectin production related to post-cardiac transplant arteriopathy in piglets, Circulation, 88, II248

Karnovsky, 1994, Chronic rejection in experimental cardiac transplantation in a rat model, Clin Transplant, 8, 308

Boisvert, 1998, A leukocyte homologue of the IL-8 receptor CXCR-2 mediates the accumulation of macrophages in atherosclerotic lesions of LDL receptor-deficient mice, J Clin Invest, 101, 353, 10.1172/JCI1195

Pattison, 1996, RANTES chemokine expression in transplant-associated accelerated atherosclerosis, J Heart Lung Transplant, 15, 1194

Shaddy, 1992, Effects of T cells on platelet-derived growth factor-like protein secretion from endothelial cells, J Heart Lung Transplant, 11, 48

Hosenpud, 1996, Cardiac allograft vasculopathy: Preferential regulation of endothelial cell-derived mesenchymal growth factors in response to a donorspecific cell-mediated allogeneic response, Transplantation, 61, 939, 10.1097/00007890-199603270-00017

Motomura, 1997, Acceleration of arteriosclerosis of the rat aorta allograft by insulin growth factor-I, Transplantation, 63, 932, 10.1097/00007890-199704150-00004

Motomura, 1998, Exposure of vascular allografts to insulin-like growth factor-I (IGF-I) increases vascular expression of IGF-I ligand and receptor protein and accelerates arteriosclerosis in rats, Transplantation, 65, 1024, 10.1097/00007890-199804270-00003

Granville, 1998, Apoptosis: Molecular aspects of cell death and disease, Lab Invest, 78, 893

Stehlik, 1998, Nuclear factor (NF)-kappa B-regulated X-chromosome-linked iap gene expression protects endothelial cells from tumor necrosis factoralpha-induced apoptosis, J Exp Med, 188, 211, 10.1084/jem.188.1.211

Sata, 1998, TNF-alpha regulation of Fas ligand expression on the vascular endothelium modulates leukocyte extravasation, Nature Med, 4, 415, 10.1038/nm0498-415

Sata, 1998, Oxidized LDL activates Fas-mediated endothelial cell apoptosis, J Clin Invest, 102, 1682, 10.1172/JCI3531

Armstrong, 1996, Morphometric and immunocytochemical analysis of coronary arterioles in human transplanted hearts, J Heart Lung Transplant, 15, 818

Billingham, 1992, Histopathology of graft coronary disease, J Heart Lung Transplant, 11, S38

Adams, 1989, Hypercholesterolemia does not exacerbate arterial intimal thickening in chronically rejecting rat cardiac allografts, Transplant Proc, 21, 437

Ross, 1993, The pathogenesis of atherosclerosis: A perspective for the 1990s, Nature, 362, 801, 10.1038/362801a0

Sanders, 1994, Molecular and cellular concepts in atherosclerosis, Pharmacol Ther, 61, 109, 10.1016/0163-7258(94)90060-4

Basha, 1996, Atherosclerosis. An update, Am Heart J, 131, 1192, 10.1016/S0002-8703(96)90096-4

Clausell, 1993, Upregulation of fibronectin synthesis by interleukin-1 beta in coronary artery smooth muscle cells is associated with the development of the post-cardiac transplant arteriopathy in piglets, J Clin Invest, 92, 1850, 10.1172/JCI116776

Molossi, 1995, Reciprocal induction of tumor necrosis factor-alpha and interleukin-1 beta activity mediates fibronectin synthesis in coronary artery smooth muscle cells, J Cell Physiol, 163, 19, 10.1002/jcp.1041630104

Akyurek, 1996, Smooth muscle cell migration into intima and adventitia during development of transplant vasculopathy, Transplantation, 62, 1526, 10.1097/00007890-199611270-00029

Alpers, 1996, Identification of platelet-derived growth factor A and B chains in human renal vascular rejection, Am J Pathol, 148, 439

Floege, 1998, Expression of PDGF alpha-receptor in renal arteriosclerosis and rejecting renal transplants, J Am Soc Nephrol, 9, 211, 10.1681/ASN.V92211

Lou, 1996, L-arginine prevents heart transplant arteriosclerosis by modulating the vascular cell proliferative response to insulin-like growth factor-I and interleukin-6, J Heart Lung Transplant, 15, 1248

Mennander, 1993, Intimal thickening and medial necrosis in allograft arteriosclerosis (chronic rejec-tion) are independently regulated, Arterioscler Thromb Vasc Biol, 13, 1019, 10.1161/01.ATV.13.7.1019

Bjorkerud, 1996, Apoptosis is abundant in human atherosclerotic lesions, especially in inflammatory cells (macrophages and T cells), and may contribute to the accumulation of gruel and plaque instability, Am J Pathol, 149, 367

Lee, 1997, The unstable atheroma, Arterioscler Thromb Vasc Biol, 17, 1859, 10.1161/01.ATV.17.10.1859

Isner, 1995, Apoptosis in human atherosclerosis and restenosis, Circulation, 91, 2703, 10.1161/01.CIR.91.11.2703

Han, 1995, Evidence for apoptosis in human atherogenesis and in a rat vascular injury model, Am J Pathol, 147, 267

Bennett, 1995, Apoptosis of human vascular smooth muscle cells derived from normal vessels and coronary atherosclerotic plaques, J Clin Invest, 95, 2266, 10.1172/JCI117917

Nose, 1996, Vascular lesions in mice with a deficit in Fas-mediated apoptosis and their transfer, Int J Cardiol, 54, S11, 10.1016/S0167-5273(96)88771-7

Libby, 1991, Involvement of the immune system in human atherogenesis: Current knowledge and unanswered questions, Lab Invest, 64, 5

Evanko, 1998, Proteoglycan distribution in lesions of atherosclerosis depends on lesion severity, structural characteristics, and the proximity of platelet-derived growth factor and transforming growth factor-β, Am J Pathol, 152, 533

Wight, 1997, Selective deposits of versican in the extracellular matrix of restenotic lesions from human peripheral arteries, Am J Pathol, 151, 963

Schonherr, 1991, Effects of platelet-derived growth factor and transforming growth factor-beta 1 on the synthesis of a large versican-like chondroitin sulfate proteoglycan by arterial smooth muscle cells, J Biol Chem, 266, 17640, 10.1016/S0021-9258(19)47419-X

Schonherr, 1993, Platelet-derived growth factor and transforming growth factor-beta 1 differentially affect the synthesis of biglycan and decorin by monkey arterial smooth muscle cells, Arterioscler Thromb Vasc Biol, 13, 1026, 10.1161/01.ATV.13.7.1026

Edwards, 1994, Interleukin-1 upregulates decorin production by arterial smooth muscle cells, Arterioscler Thromb Vasc Biol, 14, 1032, 10.1161/01.ATV.14.7.1032

Schonherr, 1997, Genistein selectively inhibits platelet-derived growth factor-stimulated versican biosynthesis in monkey arterial smooth muscle cells, Arch Biochem Biophys, 339, 353, 10.1006/abbi.1996.9854

Liu, 1998, PDGF-induced glycosaminogly-can synthesis is mediated via phosphatidylinositol 3-kinase, Am J Physiol, 274, L702

Deudon, 1992, Growth-related production of proteoglycans and hyaluronic acid in synchronous arterial smooth muscle cells, Int J Biochem, 24, 465, 10.1016/0020-711X(92)90040-8

Breton, 1986, Synthesis of sulfated proteoglycans throughout the cell cycle in smooth muscle cells from pig aorta, Exp Cell Res, 166, 416, 10.1016/0014-4827(86)90487-8

Tao, 1997, Elevated expression of proteoglycans in proliferating vascular smooth muscle cells, Atherosclerosis, 135, 171, 10.1016/S0021-9150(97)00158-5

Dreher, 1990, Vascular smooth muscle biglycan represents a highly conserved proteoglycan within the arterial wall, Eur J Cell Biol, 53, 296

Emoto, 1998, Growth factors increase pericellular proteoglycans independently of their mitogenic effects on A10 rat vascular smooth muscle cells, Int J Biochem Cell Biol, 30, 47, 10.1016/S1357-2725(97)00106-4

Rasmussen, 1995, Vascular smooth muscle cells from injured rat aortas display elevated matrix production associated with transforming growth factor-beta activity, Am J Pathol, 147, 1041

Hidalgo, 1995, Scanning electron microscopic changes in morphology of pulmonary endothelium in rat lung isografts following hypothermic ischaemic storage and transplantation, Int J Exp Pathol, 76, 339

Hidalgo, 1996, Cold ischemia-induced damage to vascular endothelium results in permeability alterations in transplanted lungs, J Thorac Cardiovasc Surg, 112, 1027, 10.1016/S0022-5223(96)70104-6

Mii, 1990, Intimal thickening and permeability of arterial autogenous vein graft in a canine poor-runoff model: Transmission electron microscopic evidence, Surgery, 108, 81

Eguchi, 1991, Significance of the endothelial lining in prevention of intimal thickening of autogenous vein grafts in dogs, J Surg Res, 50, 179, 10.1016/0022-4804(91)90244-G

Forbes, 1983, A controlled serial ultrastructural tracer study of first-set cardiac allograft rejection in the rat. Evidence that the microvascular endothelium is the primary target of graft destruction, Am J Pathol, 111, 184

Couffinhal, 1997, Vascular endothelial growth factor/vascular permeability factor (VEGF/VPF) in normal and atherosclerotic human arteries, Am J Pathol, 150, 1673

Torry, 1995, Vascular endothelial growth factor expression in transplanted human hearts, Transplantation, 60, 1451, 10.1097/00007890-199560120-00014

Abedi, 1997, Vascular endothelial growth factor stimulates tyrosine phosphorylation and recruitment to new focal adhesions of focal adhesion kinase and paxillin in endothelial cells, J Biol Chem, 272, 15442, 10.1074/jbc.272.24.15442

Schmid, 1995, Lymphocyte adhesion to human endothelial cells induces tissue factor expression via a juxtacrine pathway, Thromb Haemost, 73, 421, 10.1055/s-0038-1653791

Damle, 1990, Ability of human T lymphocytes to adhere to vascular endothelial cells and to augment endothelial permeability to macromolecules is linked to their state of post-thymic maturation, J Immunol, 144, 1233, 10.4049/jimmunol.144.4.1233

Damle, 1989, IL-2-activated human killer lymphocytes but not their secreted products mediate increase inalbumin flux across cultured endothelial monolayers. Implications for vascular leak syndrome, J Immunol, 142, 2660, 10.4049/jimmunol.142.8.2660

Ricard, 1997, Clustering the adhesion molecules VLA-4 (CD49d/CD29) in Jurkat T cells or VCAM-1 (CD 106) in endothelial (ECV 304) cells activates the phosphoinositide pathway and triggers Ca2+ mobilization, Eur J Immunol, 27, 1530, 10.1002/eji.1830270632

Gurubhagavatula, 1998, Engagement of human PECAM-1 (CD31) on human endothelial cells increases intracellular calcium ion concentration and stimulates prostacyclin release, J Clin Invest, 101, 212, 10.1172/JCI269

Pfau, 1995, Lymphocyte adhesiondependent calcium signaling in human endothelial cells, J Cell Biol, 128, 969, 10.1083/jcb.128.5.969

Lorenzon, 1998, Endothelial cell E- and P-selectin and vascular cell adhesion molecule-1 function as signaling receptors, J Cell Biol, 142, 1381, 10.1083/jcb.142.5.1381

Huang, 1993, Endothelial cell cytosolic free calcium regulates neutrophil migration across monolayers of endothelial cells, J Cell Biol, 120, 1371, 10.1083/jcb.120.6.1371

Baldwin, 1995, Complement in organ transplantation. Contributions to inflammation, injury, and rejection, Transplantation, 59, 797, 10.1097/00007890-199503000-00001

Zales, 1993, Spectrum of humoral rejection after pediatric heart transplantation, J Heart Lung Transplant, 12, 563

Brauer, 1995, The contribution of terminal complement components to acute and hyperacute allograft rejection in the rat, Transplantation, 59, 288, 10.1097/00007890-199501000-00023

Kolb, 1996, Presensitization accelerates allograft arteriosclerosis, Transplantation, 62, 1401, 10.1097/00007890-199611270-00005

Saadi, 1995, Transient perturbation of endothelial integrity induced by natural antibodies and complement, J Exp Med, 181, 21, 10.1084/jem.181.1.21

Suttorp, 1989, Terminal complement complex and endothelial cells, Z Kardiol, 78, 140

Pruitt, 1997, Effect of continuous complement inhibition using soluble complement receptor type 1 on survival of pig-to-primate cardiac xenografts, Transplantation, 63, 900, 10.1097/00007890-199703270-00017

Jakobs, 1998, Prolonged discordant xenograft survival by inhibition of the intrinsic coagulation pathway in complement C6-deficient recipients, J Heart Lung Transplant, 17, 306

Davis, 1995, Inhibition of neutrophil adhesion and the membrane attack complex of complement synergistically prolongs cardiac xenograft survival, J Heart Lung Transplant, 14, 973

Qian, 1998, Complement contributes to the rejection of complete and class I major histocompatibility complex—incompatible cardiac allografts, J Heart Lung Transplant, 17, 470

Tanaka, 1992, CD31 expressed on distinctive T cell subsets is a preferential amplifier of beta 1 integrin-mediated adhesion, J Exp Med, 176, 245, 10.1084/jem.176.1.245

Berman, 1995, Ligation of platelet/endothelial cell adhesion molecule 1 (PECAM-1/CD31) on monocytes and neutrophils increases binding capacity of leukocyte CR3 (CD11b/CD18), J Immunol, 154, 299, 10.4049/jimmunol.154.1.299

Piali, 1993, Murine platelet endothelial cell adhesion molecule (PECAM-1)/CD31 modulates beta 2 integrins on lymphokine-activated killer cells, Eur J Immunol, 23, 2464, 10.1002/eji.1830231013

Nielsen, 1996, Transfer of low-density lipoprotein into the arterial wall and risk of atherosclerosis, Atherosclerosis, 123, 1, 10.1016/0021-9150(96)05802-9

van Hinsbergh, 1983, Low-density lipoprotein metabolism by endothelial cells from human umbilical cord arteries and veins, Arteriosclerosis, 3, 547, 10.1161/01.ATV.3.6.547

Vasile, 1983, Visualization of the binding, endocytosis, and transcytosis of low-density lipoprotein in the arterial endothelium in situ, J Cell Biol, 96, 1677, 10.1083/jcb.96.6.1677

Robinson, 1985, Differential endocytosis of lipoproteins by capillary endothelial vesicles, Microcirc Endothel Lymph, 2, 313

Descamps, 1997, Effects of tumor necrosis factor on receptor-mediated endocytosis and barrier functions of bovine brain capillary endothelial cell monolayers, J Neuroimmunol, 74, 173, 10.1016/S0165-5728(96)00226-3

Sprague, 1987, Influence of a laminar steady-state fluid-imposed wall shear stress on the binding, internalization, and degradation of low-density lipoproteins by cultured arterial endothelium, Circulation, 76, 648, 10.1161/01.CIR.76.3.648

Holland, 1992, Atherogenic levels of low-density lipoprotein increase endocytotic activity in cultured human endothelial cells, Am J Pathol, 140, 551

Winters, 1990, Posttransplant obesity and hyperlipidemia: Major predictors of severity of coronary arteriopathy in failed human heart allografts, J Heart Transplant, 9, 364

Vijayagopal, 1996, Isolation and characterization of a proteoglycan variant from human aorta exhibiting a marked affinity for low-density lipoprotein and demonstration of its enhanced expression in atherosclerotic plaques, Atherosclerosis, 127, 195, 10.1016/S0021-9150(96)05954-0

Camejo, 1993, Binding of low-density lipoproteins by proteoglycans synthesized by proliferating and quiescent human arterial smooth muscle cells, J Biol Chem, 268, 14131, 10.1016/S0021-9258(19)85218-3

Kruse, 1996, Cholesterol-dependent changes of glycosaminoglycan pattern in human aorta, Basic Res Cardiol, 91, 344, 10.1007/BF00788713

Hurt-Camejo, 1992, Effect of arterial proteoglycans and glycosaminoglycans on low-density lipoprotein oxidation and its uptake by human macrophages and arterial smooth muscle cells, Arterioscler Thromb Vasc Biol, 12, 569, 10.1161/01.ATV.12.5.569

Vijayagopal, 1993, Enhanced synthesis and accumulation of proteoglycans in cholesterol-enriched arterial smooth muscle cells, Biochem J, 294, 603, 10.1042/bj2940603

Vijayagopal, 1996, Marked alteration of proteoglycan metabolism in cholesterol-enriched human arterial smooth muscle cells, Biochem J, 315, 995, 10.1042/bj3150995

Camejo, 1991, Modification of copper-catalyzed oxidation of low-density lipoprotein by proteoglycans and glycosaminoglycans, J Lipid Res, 32, 1983, 10.1016/S0022-2275(20)41901-7

Oorni, 1997, Oxidation of low-density lipoprotein particles decreases their ability to bind to human aortic proteoglycans. Dependence on oxidative modification of the lysine residues, J Biol Chem, 272, 21303, 10.1074/jbc.272.34.21303

Steinbrecher, 1990, Role of oxidatively modified LDL in atherosclerosis, Free Radic Biol Med, 9, 155, 10.1016/0891-5849(90)90119-4

Steinberg, 1997, Low-density lipoprotein oxidation and its pathobiological significance, J Biol Chem, 272, 20963, 10.1074/jbc.272.34.20963

Hajjar, 1997, Lipoprotein trafficking in vascular cells. Molecular Trojan horses and cellular saboteurs, J Biol Chem, 272, 22975, 10.1074/jbc.272.37.22975

Kuzuya, 1995, Induction of angiogenesis by smooth muscle cell-derived factor: Possible role in neovascularization in atherosclerotic plaque, J Cell Physiol, 164, 658, 10.1002/jcp.1041640324

Allen, 1998, Native low-density lipoprotein-induced calcium transients trigger VCAM-1 and E-selectin expression in cultured human vascular endothelial cells, J Clin Invest, 101, 1064, 10.1172/JCI445

Chatterjee, 1996, Oxidized low-density lipoprotein stimulates aortic smooth muscle cell proliferation, Glycobiology, 6, 303, 10.1093/glycob/6.3.303

Chatterjee, 1992, Role of oxidized human plasma low-density lipoproteins in atherosclerosis: Effects on smooth muscle cell proliferation, Mol Cell Biochem, 111, 143, 10.1007/BF00229586

Gorog, 1997, Modified low-density lipoprotein is a potent stimulus for smooth muscle cell outgrowth from rat aortic explant in vitro, Atherosclerosis, 129, 1, 10.1016/S0021-9150(96)06000-5

Auge, 1998, Potential role for ceramide in mitogen-activated protein kinase activation and proliferation of vascular smooth muscle cells induced by oxidized low-density lipoprotein, J Biol Chem, 273, 12893, 10.1074/jbc.273.21.12893

Oinuma, 1997, Effects of copper-zinc type Superoxide dismutase on the proliferation and migration of cultured vascular smooth muscle cells induced by oxidized low density lipoprotein, J Atheroscler Thromb, 4, 79, 10.5551/jat1994.4.79

Gorog, 1998, Inhibition of vascular smooth muscle cell migration by intact endothelium is nitric oxide-mediated: Interference by oxidised low-density lipoproteins, J Vasc Res, 35, 165, 10.1159/000025580

Dulak, 1997, Regulation of inducible nitric oxide synthase (iNOS) and GTP cyclohydrolase I (GTP-CH I) gene expression by ox-LDL in rat vascular smooth muscle cells, J Physiol Pharmacol, 48, 689

Ishigami, 1998, Apolipoprotein E inhibits platelet-derived growth factor-induced vascular smooth muscle cell migration and proliferation by suppressing signal transduction and preventing cell entry to G1 phase, J Biol Chem, 273, 20156, 10.1074/jbc.273.32.20156

Dimmeler, 1997, Nitric oxide and apoptosis: Another paradigm for the double-edged role of nitric oxide, Nitric Oxide, 1, 275, 10.1006/niox.1997.0133

Green, 1998, Mitochondria and apoptosis, Science, 281, 1309, 10.1126/science.281.5381.1309

Drew, 1995, Cyclosporine treatment reduces early atherosclerosis in the cholesterol- fed rabbit, Atherosclerosis, 116, 181, 10.1016/0021-9150(95)05539-9

Handa, 1993, Late Cyclosporine treatment ameliorates established coronary graft disease in rat allografts, Transplantation, 56, 535, 10.1097/00007890-199309000-00009

Vriens, 1998, The use of technetium Tc 99m annexin V for in vivo imaging of apoptosis during cardiac allograft rejection, J Thorac Cardiovasc Surg, 116, 844, 10.1016/S0022-5223(98)00446-2

Bellon, 1995, Atherogenic effects of Cyclosporine in an experimental model of arterial autograft, Transplantation, 60, 407, 10.1097/00007890-199509000-00002

Roselaar, 1995, Enhanced development of atherosclerosis in cholesterol-fed rabbits by suppression of cell-mediated immunity, J Clin Invest, 96, 1389, 10.1172/JCI118174

Dimmeler, 1997, Suppression of apoptosis by nitric oxide via inhibition of interleukin-1betaconverting enzyme (ICE)-like and cysteine protease protein (CPP)-32-like proteases, J Exp Med, 185, 601, 10.1084/jem.185.4.601

Ren, 1998, Apoptosis: The importance of being eaten, Cell Death Differ, 5, 563, 10.1038/sj.cdd.4400407

Fadok, 1998, The role of phosphatidylserine in recognition of apoptotic cells by phagocytes, Cell Death Differ, 5, 551, 10.1038/sj.cdd.4400404

Sambrano, 1995, Recognition of oxidatively damaged and apoptotic cells by an oxidized low-density lipoprotein receptor on mouse peritoneal macrophages: Role of membrane phosphatidylserine, 92, 1396

Oka, 1998, Lectin-like oxidized low-density lipoprotein receptor 1 mediates phagocytosis of aged/apoptotic cells in endothelial cells, 95, 9535

Bevers, 1998, Transmembrane phospholipid distribution in blood cells: Control mechanisms and pathophysiological significance, Biol Chem, 379, 973

Kinscherf, 1997, Induction of mitochondrial manganese Superoxide dismutase in macrophages by oxidized LDL: Its relevance in atherosclerosis of humans and heritable hyperlipidemic rabbits, FASEB J, 11, 1317, 10.1096/fasebj.11.14.9409551

Yun, 1997, Inflammatory mediators are perpetuated in macrophages resistant to apoptosis induced by hypoxia, 94, 13903

Russell, 1995, Macrophages and transplant arteriosclerosis: Known and novel molecules, J Heart Lung Transplant, 14, S111

Russell, 1997, Graft arteriosclerosis: Molecular features of macrophage activation, Transplant Proc, 29, 2542, 10.1016/S0041-1345(97)00499-5

Liu, 1998, Nitric oxide and endothelin in the development of cardiac allograft vasculopathy—Potential targets for therapeutic interventions, Atherosclerosis, 140, 1, 10.1016/S0021-9150(98)00106-3

Akyurek, 1996, Inducible and endothelial nitric oxide synthase expression during development of transplant arteriosclerosis in rat aortic grafts, Am J Pathol, 149, 1981

Lafond-Walker, 1997, Inducible nitric oxide synthase expression in coronary arteries of transplanted human hearts with accelerated graft arteriosclerosis, Am J Pathol, 151, 919

Dusting, 1995, Endogenous nitric oxide in cardiovascular disease and transplantation, Ann Med, 27, 395, 10.3109/07853899509002593

Shears, 1997, Inducible nitric oxide synthase suppresses the development of allograft arteriosclerosis, J Clin Invest, 100, 2035, 10.1172/JCI119736

Little, 1995, Connexin 43 and connexin 40 gap junctional proteins are present in arteriolar smoothmuscle and endothelium in vivo, Am J Physiol, 268, H729

Hu, 1997, Differential regulation of gap junctions by proinflammatory mediators in vitro, J Clin Invest, 99, 2312, 10.1172/JCI119410

Haas, 1997, Morphology favors an endothelial cell pathway for longitudinal conduction within arterioles, Microvasc Res, 53, 113, 10.1006/mvre.1996.1999

Chaytor, 1998, Central role of heterocellular gap junctional communication in endotheliumdependent relaxations of rabbit arteries, J Physiol, 508, 561, 10.1111/j.1469-7793.1998.561bq.x